The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy-Reference-Cited by-同舟云学术

The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy

Published:2021-06-23 Issue:599 Volume:13 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

SenGupta Devi¹^ORCID,Brinson Cynthia²^ORCID,DeJesus Edwin³,Mills Anthony⁴^ORCID,Shalit Peter⁵,Guo Susan¹,Cai Yanhui¹,Wallin Jeffrey J.¹,Zhang Liao¹,Humeniuk Rita¹,Begley Rebecca¹,Geleziunas Romas¹,Mellors John⁶^ORCID,Wrin Terri⁷,Jones Norman⁸,Milush Jeffrey⁸,Ferre April L.⁹,Shacklett Barbara L.⁹^ORCID,Laird Greg M.¹⁰^ORCID,Moldt Brian¹,Vendrame Elena¹^ORCID,Brainard Diana M.¹,Ramgopal Moti¹¹^ORCID,Deeks Steven G.⁸^ORCID

Affiliation:

1. Gilead Sciences Inc., Foster City, CA, USA.

2. Central Texas Clinical Research, Austin, TX, USA.

3. Orlando Immunology Center, Orlando, FL, USA.

4. Men’s Health Foundation, West Hollywood, CA, USA.

5. Peter Shalit MD and Associates, Seattle, WA, USA.

6. University of Pittsburgh, Pittsburg, PA, USA.

7. Monogram Biosciences, South San Francisco, CA, USA.

8. University of California San Francisco, San Francisco, CA, USA.

9. University of California Davis, Davis, CA, USA.

10. Accelevir Diagnostics, Baltimore, MD, USA.

11. Midway Specialty Care Center, Fort Pierce, FL, USA.